Search

Your search keyword '"Fukaya, Yasuo"' showing total 12 results
Start Over Author "Fukaya, Yasuo"
12 results on '"Fukaya, Yasuo"'

1. Long-term efficacy and safety of difelikefalin in moderate-to-severe pruritus in Japanese hemodialysis patients: a 52-week open-label extension period of a phase 3 trial.

Author

Narita, Ichiei, Tsubakihara, Yoshiharu, Takahashi, Naoko, Ebata, Toshiya, Uchiyama, Takuma, Marumo, Masaya, Okamura, Shota, Gejyo, Fumitake, Fukaya, Yasuo, Yajima, Takahiro, Hamamoto, Yukihiro, Hagiwara, Noriyasu, Itami, Noritomo, Komeda, Masami, Kim, Jong Il, Hattori, Hideaki, Ishii, Sakae, Imanishi, Masahito, Funakoshi, Satoshi, and Ohsawa, Isao

Published
2024
Full Text
View/download PDF

3. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

Author

Kimura, Kenjiro, primary, Hosoya, Tatsuo, additional, Uchida, Shunya, additional, Inaba, Masaaki, additional, Makino, Hirofumi, additional, Maruyama, Shoichi, additional, Ito, Sadayoshi, additional, Yamamoto, Tetsuya, additional, Tomino, Yasuhiko, additional, Ohno, Iwao, additional, Shibagaki, Yugo, additional, Iimuro, Satoshi, additional, Imai, Naohiko, additional, Kuwabara, Masanari, additional, Hayakawa, Hiroshi, additional, Ohtsu, Hiroshi, additional, Ohashi, Yasuo, additional, Kimura, Kenjiro, additional, Matsuo, Seiichi, additional, Yamanaka, Hisashi, additional, Akizawa, Tadao, additional, Teramoto, Tamio, additional, Kasanuki, Hiroshi, additional, Yoshimura, Kenichi, additional, Sato, Hiroshi, additional, Horikoshi, Satoshi, additional, Maruyama, Syoichi, additional, Inaba, Masahiko, additional, Moriwaki, Yuji, additional, Uchida, Haruhito, additional, Kaneshiro, Nagayuki, additional, Moriya, Hidekazu, additional, Komatsu, Yasuhiro, additional, Kaname, Shinya, additional, Hanaoka, Kazunari, additional, Ogura, Makoto, additional, Ikeda, Masato, additional, Kasai, Kenji, additional, Sugiura, Akira, additional, Takahashi, Kazushi, additional, Kojima, Kenichiro, additional, Nitta, Kosaku, additional, Tamai, Hirofumi, additional, Nagaya, Hiroshi, additional, Okuno, Senji, additional, Kakiya, Ryusuke, additional, Takeoka, Hiroya, additional, Hirata, Kyouji, additional, Asano, Kenichiro, additional, Fukaya, Yasuo, additional, Iwaida, Yasushi, additional, Tsuneda, Yasuo, additional, Nishimura, Shigeaki, additional, Hiramatsu, Takeyuki, additional, Isaka, Yoshitaka, additional, Ito, Takafumi, additional, Yuzawa, Yukio, additional, Yamagata, Kunihiro, additional, Sofue, Tadashi, additional, Jinguji, Yoshimi, additional, Hirano, Keita, additional, Matsuyama, Kazuhiro, additional, Mizumoto, Teruhiko, additional, Shibuya, Yuko, additional, Sugawara, Masahiro, additional, Kadomura, Moritoshi, additional, Teshima, Yasuaki, additional, Ohtani, Hiroshi, additional, Kamata, Hiroki, additional, Okawara, Susumu, additional, Fukushima, Masaki, additional, Takemura, Katsumi, additional, Kinugasa, Eriko, additional, Kogure, Masami, additional, and Ehara, Yoichi, additional

Published
2018
Full Text
View/download PDF

5. Effect of KT-611 (Naftopidil) on the contraction of human prostatic tissue and its use in benign prostatic obstruction

Author

Yamanaka, Naoto, Yamaguchi, Osamu, Kameoka, Hiroshi, Fukaya, Yasuo, Yokota, Takashi, Shiraiwa, Yasuo, Yokoyama, Jun, Kumakawa, Kenjirou, Itou, Kenji, Kuma, Yoshinobu, Kobayashi, Masato, and Takaiwa, Masashi

Subjects
arblocker, 494.9, KT-611 (naftopidil), Benign prostatic hypertrophy
Abstract

良性前立腺肥大症49例で1日1或いは2回本剤を投与した所, 自・他覚的症状は有意に改善された.残尿量及び残尿率は有意に減少した.平均及び最大尿流量率は有意に増加した.適正量は, 1日1回, 25～75 mg, 或いは1日2回, 25～100 mgと思われた.有害反応及び異常な臨床検査所見は軽度であった, A new alpha 1-adrenergic receptor antagonist, KT-611 (naftopidil) antagonized dose dependently the contraction induced by agonists, noradrenaline and phenylephrine in the human prostatic tissue. KT-611 at a dosage of once or twice a day was evaluated for its effects on 49 patients with benign prostatic hypertrophy. The drug improved subjective and objective symptoms significantly. The residual urine was reduced in volume and percentage significantly. The average and maximum flow rates increased significantly. The optimal dosage was presumed to be in the range of 25 to 75 mg once a day or 25 to 100 mg twice a day. Adverse reactions and abnormal laboratory findings were all slight. KT-611 was concluded to be useful in the treatment of patients with benign prostatic hypertrophy.

Published
1991

8. Neurogenic bladder due to the anterior spinal artery syndrome: 2 case reports

Author

ITOH, Kenji, YAMAGUCHI, Osamu, FUKAYA, Yasuo, and SHIRAIWA, Yasuo

Subjects
Neurogenic bladder, 494.9, Anterior spinal artery syndrome
Abstract

A 43-year-old woman with anterior spinal artery syndrome was admitted with complaints of tetraplegia and urinary retention. Her bladder had capacity of more than 500 ml and was inactive, with low voltage of external urethral sphincter. She was treated with distigmine bromide and intermittent catheterization. 50 days later, urodynamic study showed normal bladder and incomplete coordination of external sphincter. A 78-year-old man had chief complaints of urinary retention and paraplegia. A catheter was left indwell for 6 months. Then he was treated with intermittent catheterization, but urgency incontinence was still observed. We discussed the therapy of neurogenic bladder due to the anterior spinal artery syndrome.

Published
1987

9. 精索転移をきたした腎癌の1例

Author

IRISAWA, Chiharu, KOGUCHI, Masahide, FUKAYA, Yasuo, and YAMAGUCHI, Osamu

Subjects
Spermatic cord, Metastatic tumor, 494.9, urologic and male genital diseases, Renal cell carcinoma
Abstract

The patient was a 54-year-old man with a hard nodule (25 x 15 mm) in his left scrotum. His left spermatic vein had been ligated 6 months earlier because of a varicocele. Preoperative diagnosis was left renal tumor with multiple lung metastasis. The intrascrotal nodule was considered to be a metastatic tumor from renal cell carcinoma. Left nephrectomy was performed and the metastatic lesion of spermatic cord was also removed. Pathological examination showed that the left renal tumor was renal cell carcinoma (clear cell type). The spermatic cord nodule was tumor embolus in dilated veins and consisted of the same clear cells as renal cell carcinoma. Judging from these results, in this case renal cell carcinoma retrogradely metastasized through the spermatic vein to the intrascrotal lesion.

Published
1988

Catalog

Books, media, physical & digital resources
See catalog results